DSS, INC. Ownership Filing

DSS, INC., a ten percent owner of IMPACT BIOMEDICAL INC., reported several transactions on September 22, 23, and 24, 2026. The company disposed of 723 shares of Common Stock at $0.55 per share on September 22, followed by the disposal of 27 shares at $6.95 per share on September 23, and 156 shares at $7.0587 per share on September 24. These transactions resulted in a decrease in their post-transaction shares, with the final reported holding being 589,518 shares. The filing also notes that IMPACT BIOMEDICAL INC. is a wholly-owned subsidiary of DSS, Inc.